Is California Planning to Sell Its Own Generic Drugs?
California's Democratic Governor Gavin Newsom earlier this month proposed his potential solution to reduce drug prices: have the state manufacture [...]
JMCP Welcomes Prominent Researchers to Editorial Team
The Journal of Managed Care & Specialty Pharmacy (JMCP) is welcoming two prominent health care researchers to its editorial team [...]
CVS Releases Health Trends Report for 2020
CVS Health this week released its "Health Trends 2020" report which identifies six key trends in the health care industry, [...]
American College of Physicians Backs Medicare for All
The nation's second-largest doctors group, the American College of Physicians (ACP), is officially endorsing Medicare for All and a public [...]
New Framework Introduces New Metric in Cost-Effectiveness Analysis
A recent article published in Value in Health proposes a new framework for valuing health outcomes in cost-effectiveness analyses and [...]
Concerto HealthAI Announces Funding, Partnerships at J.P. Morgan Conference
Concerto HealthAI during the J.P. Morgan Healthcare Conference announced it had secured $150 million in a new round of funding [...]
CVS, Cigna Talk M&A, Election Year
CVS and Cigna executives during the annual J.P. Morgan Healthcare Conference discussed consolidation in the insurance sector and the upcoming [...]
Dems Talk Drug Prices During Debate
Presidential hopefuls discussed ways to address high drug prices during Tuesday night's Democratic debate. According to a brief by STAT, [...]
Are FDA Approvals Less Rigorous?
A recent study suggests that legislative changes to how the Food and Drug Administration (FDA) evaluates drugs may have ultimately [...]
With $200M in Funding, Pharma Startup Wants to Bring New Drugs in ‘Sustainable Method’
With $200 million in startup funding, a new Massachusetts-based drug company called EQRx is looking to shake up the pharmaceutical [...]
Concerto HealthAI Launches New RWE Solution
Concerto HealthAI on Monday, Jan. 13, announced the launch of its new real-world evidence platform, eurekaHealth 3.0, which combines real-world [...]
Article: Stop Putting All the Blame on PBMs
Jack Kemp Foundation's Ike Brannon and DePaul University's Tony LoSasso in a recent article published on Bloomberg Law say pinning [...]
Providers’ ‘Deeply Ingrained’ Model Disrupts Shift to Value
While providers claim a number of reasons for their reluctance to shift to risk-based deals, Numerof & Associates' Rita Numerof [...]
Frakt Outlines Major Study on Health Spending
Austin Frakt in a recent article highlights some of the key findings in a study published Monday, Jan. 6, in [...]
Pharma Execs Support New Commitment to Patients
A group of pharmaceutical executives has pledged its support for a renewed effort to put the patient first after signing [...]
Evidera White Paper Highlights PPI in Europe
A recent white paper by Evidera, "Patient Preferences in Health Technology Assessment in Europe: Recent Advances and Future Potential," spotlights [...]
Researchers Find ICER Makes ‘Modest’ Revisions Based on Comments
Tufts Medical Center researchers in a recent article published in Value in Health found that the Institute for Clinical and [...]
ICER Outlines Planned Review for Beta Thalassemia Treatments
The Institute for Clinical and Economic Review (ICER) on Monday released a new document outlining a planned review of LentiGlobin [...]
NPR Blog: Global Trends to Watch in 2020
NPR in a recent blog post highlights some key global trends to watch in 2020, including rising demand for humanitarian [...]
Using Innovative Data Analytics for Market Access
Dr. Patti Peeples, CEO of HealthEconomics.com, sat down with Walter Bouwmeester, Real-World Evidence and Data Analytics Lead in Europe, to discuss the use of data analytics to support multidimensional health economics and outcomes research (HEOR) in Europe.
Changing the Clinical Trial Paradigm for Rare and Orphan (R&O) Diseases using Real-World Evidence
Interview with Flora Sandra Siami, MPH. Vice President of Clinical Research, Regulatory Affairs, and Quality Assurance at HealthCore-NERI. Dr. Patti [...]
Benchmarking Survey: Can we reduce procurement time in HEOR & RWE?
As healthcare moves towards an increased focus on outcomes and value, health economics & outcomes research (HEOR) and real-world evidence [...]
Pharmacy benefit managers: a mechanism for containing costs or a contributor to rising drug prices?
While pharmaceutical companies are often the focus of conversations about high drug prices, more recently pharmacy benefit managers (PBMs) have [...]
CVS Caremark’s foray into cost-effectiveness analysis raises questions about the future of prescription medicines in America
Written By: Americans spend more on prescription drugs than anyone else in the world. In a move to address this, [...]
HEOR Salaries: Big Growth in Certain Sectors. Where Do You Stand?
2017 HEOR & Market Access Salaries show big growth in key areas of Pricing, Market Access, and HEOR-focused Medical Communications. [...]